nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—prostate gland—urinary bladder cancer	0.0305	0.131	CbGeAlD
Auranofin—PRDX5—seminal vesicle—urinary bladder cancer	0.0258	0.111	CbGeAlD
Auranofin—PRDX5—epithelium—urinary bladder cancer	0.0224	0.0965	CbGeAlD
Auranofin—PRDX5—renal system—urinary bladder cancer	0.0208	0.0895	CbGeAlD
Auranofin—PRDX5—urethra—urinary bladder cancer	0.0204	0.0879	CbGeAlD
Auranofin—IKBKB—prostate gland—urinary bladder cancer	0.0181	0.0778	CbGeAlD
Auranofin—PRDX5—female reproductive system—urinary bladder cancer	0.0166	0.0717	CbGeAlD
Auranofin—PRDX5—vagina—urinary bladder cancer	0.015	0.0648	CbGeAlD
Auranofin—IKBKB—smooth muscle tissue—urinary bladder cancer	0.0128	0.0551	CbGeAlD
Auranofin—IKBKB—urethra—urinary bladder cancer	0.0121	0.0521	CbGeAlD
Auranofin—IKBKB—female reproductive system—urinary bladder cancer	0.00985	0.0425	CbGeAlD
Auranofin—PRDX5—lymph node—urinary bladder cancer	0.00973	0.0419	CbGeAlD
Auranofin—IKBKB—vagina—urinary bladder cancer	0.00891	0.0384	CbGeAlD
Auranofin—ALB—Fluorouracil—urinary bladder cancer	0.00581	0.645	CbGbCtD
Auranofin—IKBKB—lymph node—urinary bladder cancer	0.00576	0.0248	CbGeAlD
Auranofin—Interstitial pneumonia—Etoposide—urinary bladder cancer	0.00574	0.0172	CcSEcCtD
Auranofin—Flatulence—Valrubicin—urinary bladder cancer	0.0048	0.0144	CcSEcCtD
Auranofin—Interstitial lung disease—Gemcitabine—urinary bladder cancer	0.00459	0.0138	CcSEcCtD
Auranofin—Pancytopenia—Mitomycin—urinary bladder cancer	0.00457	0.0137	CcSEcCtD
Auranofin—Anaemia—Valrubicin—urinary bladder cancer	0.0045	0.0135	CcSEcCtD
Auranofin—Stomatitis—Mitomycin—urinary bladder cancer	0.00419	0.0126	CcSEcCtD
Auranofin—Interstitial lung disease—Etoposide—urinary bladder cancer	0.00392	0.0118	CcSEcCtD
Auranofin—Proteinuria—Gemcitabine—urinary bladder cancer	0.0037	0.0111	CcSEcCtD
Auranofin—Protein urine present—Gemcitabine—urinary bladder cancer	0.00365	0.0109	CcSEcCtD
Auranofin—Interstitial pneumonia—Methotrexate—urinary bladder cancer	0.00344	0.0103	CcSEcCtD
Auranofin—Hepatic enzyme increased—Gemcitabine—urinary bladder cancer	0.00343	0.0103	CcSEcCtD
Auranofin—Alopecia—Mitomycin—urinary bladder cancer	0.00341	0.0102	CcSEcCtD
Auranofin—ALB—lymph node—urinary bladder cancer	0.00336	0.0145	CbGeAlD
Auranofin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00325	0.00976	CcSEcCtD
Auranofin—ALB—Methotrexate—urinary bladder cancer	0.0032	0.356	CbGbCtD
Auranofin—Abdominal pain—Valrubicin—urinary bladder cancer	0.00314	0.00944	CcSEcCtD
Auranofin—Anaemia—Mitomycin—urinary bladder cancer	0.0031	0.00931	CcSEcCtD
Auranofin—Leukopenia—Mitomycin—urinary bladder cancer	0.003	0.00902	CcSEcCtD
Auranofin—Pruritus—Valrubicin—urinary bladder cancer	0.00281	0.00845	CcSEcCtD
Auranofin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00272	0.00817	CcSEcCtD
Auranofin—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00268	0.00805	CcSEcCtD
Auranofin—Anorexia—Mitomycin—urinary bladder cancer	0.00261	0.00784	CcSEcCtD
Auranofin—Vomiting—Valrubicin—urinary bladder cancer	0.00253	0.00759	CcSEcCtD
Auranofin—Rash—Valrubicin—urinary bladder cancer	0.00251	0.00753	CcSEcCtD
Auranofin—Dermatitis—Valrubicin—urinary bladder cancer	0.0025	0.00752	CcSEcCtD
Auranofin—Decreased appetite—Mitomycin—urinary bladder cancer	0.00238	0.00715	CcSEcCtD
Auranofin—Nausea—Valrubicin—urinary bladder cancer	0.00236	0.00709	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—urinary bladder cancer	0.00235	0.00705	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00232	0.00696	CcSEcCtD
Auranofin—Pancytopenia—Thiotepa—urinary bladder cancer	0.0023	0.00691	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.0022	0.0066	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—urinary bladder cancer	0.00212	0.00635	CcSEcCtD
Auranofin—Stomatitis—Thiotepa—urinary bladder cancer	0.00211	0.00632	CcSEcCtD
Auranofin—Jaundice—Thiotepa—urinary bladder cancer	0.00211	0.00632	CcSEcCtD
Auranofin—Conjunctivitis—Thiotepa—urinary bladder cancer	0.0021	0.0063	CcSEcCtD
Auranofin—Haematuria—Thiotepa—urinary bladder cancer	0.00206	0.00618	CcSEcCtD
Auranofin—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00202	0.00605	CcSEcCtD
Auranofin—Dysphagia—Fluorouracil—urinary bladder cancer	0.002	0.00602	CcSEcCtD
Auranofin—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00198	0.00596	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—urinary bladder cancer	0.00198	0.00595	CcSEcCtD
Auranofin—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00194	0.00581	CcSEcCtD
Auranofin—Neutropenia—Gemcitabine—urinary bladder cancer	0.00191	0.00572	CcSEcCtD
Auranofin—Pancytopenia—Fluorouracil—urinary bladder cancer	0.0019	0.00571	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—urinary bladder cancer	0.00189	0.00568	CcSEcCtD
Auranofin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00187	0.00563	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—urinary bladder cancer	0.00186	0.0056	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—urinary bladder cancer	0.00183	0.0055	CcSEcCtD
Auranofin—Eye disorder—Thiotepa—urinary bladder cancer	0.00181	0.00544	CcSEcCtD
Auranofin—Pancytopenia—Cisplatin—urinary bladder cancer	0.0018	0.00542	CcSEcCtD
Auranofin—Glossitis—Methotrexate—urinary bladder cancer	0.0018	0.00541	CcSEcCtD
Auranofin—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00178	0.00535	CcSEcCtD
Auranofin—Stomatitis—Gemcitabine—urinary bladder cancer	0.00177	0.00532	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—urinary bladder cancer	0.00176	0.00527	CcSEcCtD
Auranofin—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00175	0.00526	CcSEcCtD
Auranofin—Vomiting—Mitomycin—urinary bladder cancer	0.00174	0.00523	CcSEcCtD
Auranofin—Stomatitis—Fluorouracil—urinary bladder cancer	0.00174	0.00523	CcSEcCtD
Auranofin—Dysphagia—Etoposide—urinary bladder cancer	0.00174	0.00522	CcSEcCtD
Auranofin—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.00174	0.00521	CcSEcCtD
Auranofin—Haematuria—Gemcitabine—urinary bladder cancer	0.00173	0.0052	CcSEcCtD
Auranofin—Rash—Mitomycin—urinary bladder cancer	0.00173	0.00519	CcSEcCtD
Auranofin—Dermatitis—Mitomycin—urinary bladder cancer	0.00173	0.00518	CcSEcCtD
Auranofin—Alopecia—Thiotepa—urinary bladder cancer	0.00171	0.00514	CcSEcCtD
Auranofin—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.0017	0.00509	CcSEcCtD
Auranofin—Glossitis—Epirubicin—urinary bladder cancer	0.00169	0.00507	CcSEcCtD
Auranofin—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00167	0.00501	CcSEcCtD
Auranofin—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00166	0.00498	CcSEcCtD
Auranofin—Pancytopenia—Etoposide—urinary bladder cancer	0.00165	0.00496	CcSEcCtD
Auranofin—Stomatitis—Cisplatin—urinary bladder cancer	0.00165	0.00496	CcSEcCtD
Auranofin—Conjunctivitis—Cisplatin—urinary bladder cancer	0.00165	0.00494	CcSEcCtD
Auranofin—Neutropenia—Etoposide—urinary bladder cancer	0.00163	0.00489	CcSEcCtD
Auranofin—Nausea—Mitomycin—urinary bladder cancer	0.00163	0.00489	CcSEcCtD
Auranofin—Melaena—Methotrexate—urinary bladder cancer	0.00162	0.00487	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—urinary bladder cancer	0.00156	0.00469	CcSEcCtD
Auranofin—Anaemia—Thiotepa—urinary bladder cancer	0.00156	0.00468	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00156	0.00468	CcSEcCtD
Auranofin—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00152	0.00457	CcSEcCtD
Auranofin—Melaena—Epirubicin—urinary bladder cancer	0.00152	0.00456	CcSEcCtD
Auranofin—Stomatitis—Etoposide—urinary bladder cancer	0.00151	0.00454	CcSEcCtD
Auranofin—Jaundice—Etoposide—urinary bladder cancer	0.00151	0.00454	CcSEcCtD
Auranofin—Leukopenia—Thiotepa—urinary bladder cancer	0.00151	0.00454	CcSEcCtD
Auranofin—Visual impairment—Cisplatin—urinary bladder cancer	0.00147	0.0044	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00146	0.00438	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—urinary bladder cancer	0.00145	0.00435	CcSEcCtD
Auranofin—Alopecia—Gemcitabine—urinary bladder cancer	0.00144	0.00433	CcSEcCtD
Auranofin—Eye disorder—Cisplatin—urinary bladder cancer	0.00142	0.00427	CcSEcCtD
Auranofin—Alopecia—Fluorouracil—urinary bladder cancer	0.00142	0.00425	CcSEcCtD
Auranofin—Melaena—Doxorubicin—urinary bladder cancer	0.00141	0.00422	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00135	0.00405	CcSEcCtD
Auranofin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00135	0.00405	CcSEcCtD
Auranofin—Alopecia—Cisplatin—urinary bladder cancer	0.00134	0.00403	CcSEcCtD
Auranofin—Anorexia—Thiotepa—urinary bladder cancer	0.00131	0.00394	CcSEcCtD
Auranofin—Anaemia—Gemcitabine—urinary bladder cancer	0.00131	0.00394	CcSEcCtD
Auranofin—Flatulence—Cisplatin—urinary bladder cancer	0.0013	0.00392	CcSEcCtD
Auranofin—Eye disorder—Etoposide—urinary bladder cancer	0.0013	0.00391	CcSEcCtD
Auranofin—Anaemia—Fluorouracil—urinary bladder cancer	0.00129	0.00387	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00128	0.00384	CcSEcCtD
Auranofin—Leukopenia—Gemcitabine—urinary bladder cancer	0.00127	0.00382	CcSEcCtD
Auranofin—Leukopenia—Fluorouracil—urinary bladder cancer	0.00125	0.00375	CcSEcCtD
Auranofin—Alopecia—Etoposide—urinary bladder cancer	0.00123	0.0037	CcSEcCtD
Auranofin—Anaemia—Cisplatin—urinary bladder cancer	0.00122	0.00367	CcSEcCtD
Auranofin—Dyspepsia—Thiotepa—urinary bladder cancer	0.00121	0.00364	CcSEcCtD
Auranofin—Decreased appetite—Thiotepa—urinary bladder cancer	0.0012	0.0036	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.0012	0.00359	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—urinary bladder cancer	0.00119	0.00356	CcSEcCtD
Auranofin—Leukopenia—Cisplatin—urinary bladder cancer	0.00118	0.00356	CcSEcCtD
Auranofin—Constipation—Thiotepa—urinary bladder cancer	0.00118	0.00354	CcSEcCtD
Auranofin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00113	0.00341	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00113	0.00339	CcSEcCtD
Auranofin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00113	0.00338	CcSEcCtD
Auranofin—Anaemia—Etoposide—urinary bladder cancer	0.00112	0.00336	CcSEcCtD
Auranofin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00112	0.00335	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00111	0.00332	CcSEcCtD
Auranofin—Anorexia—Gemcitabine—urinary bladder cancer	0.0011	0.00332	CcSEcCtD
Auranofin—Urticaria—Thiotepa—urinary bladder cancer	0.00109	0.00329	CcSEcCtD
Auranofin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00109	0.00327	CcSEcCtD
Auranofin—Anorexia—Fluorouracil—urinary bladder cancer	0.00109	0.00326	CcSEcCtD
Auranofin—Leukopenia—Etoposide—urinary bladder cancer	0.00109	0.00326	CcSEcCtD
Auranofin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00106	0.00318	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00104	0.00314	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—urinary bladder cancer	0.00103	0.0031	CcSEcCtD
Auranofin—Anorexia—Cisplatin—urinary bladder cancer	0.00103	0.00309	CcSEcCtD
Auranofin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00101	0.00302	CcSEcCtD
Auranofin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.001	0.00301	CcSEcCtD
Auranofin—Constipation—Gemcitabine—urinary bladder cancer	0.000991	0.00298	CcSEcCtD
Auranofin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00099	0.00297	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—urinary bladder cancer	0.00099	0.00297	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—urinary bladder cancer	0.000975	0.00293	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—urinary bladder cancer	0.000975	0.00293	CcSEcCtD
Auranofin—Pruritus—Thiotepa—urinary bladder cancer	0.000975	0.00293	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000969	0.00291	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—urinary bladder cancer	0.000966	0.0029	CcSEcCtD
Auranofin—Anorexia—Etoposide—urinary bladder cancer	0.000943	0.00283	CcSEcCtD
Auranofin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000943	0.00283	CcSEcCtD
Auranofin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000939	0.00282	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—urinary bladder cancer	0.000926	0.00278	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—urinary bladder cancer	0.000912	0.00274	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—urinary bladder cancer	0.000906	0.00272	CcSEcCtD
Auranofin—Urticaria—Fluorouracil—urinary bladder cancer	0.000905	0.00272	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000903	0.00271	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000903	0.00271	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000894	0.00268	CcSEcCtD
Auranofin—Haematuria—Methotrexate—urinary bladder cancer	0.000886	0.00266	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—urinary bladder cancer	0.000882	0.00265	CcSEcCtD
Auranofin—Vomiting—Thiotepa—urinary bladder cancer	0.000876	0.00263	CcSEcCtD
Auranofin—Rash—Thiotepa—urinary bladder cancer	0.000869	0.00261	CcSEcCtD
Auranofin—Dermatitis—Thiotepa—urinary bladder cancer	0.000868	0.00261	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000867	0.0026	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—urinary bladder cancer	0.00086	0.00258	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000857	0.00257	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000853	0.00256	CcSEcCtD
Auranofin—Jaundice—Epirubicin—urinary bladder cancer	0.000848	0.00255	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—urinary bladder cancer	0.000848	0.00255	CcSEcCtD
Auranofin—Constipation—Etoposide—urinary bladder cancer	0.000846	0.00254	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000845	0.00254	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000844	0.00253	CcSEcCtD
Auranofin—Haematuria—Epirubicin—urinary bladder cancer	0.000829	0.00249	CcSEcCtD
Auranofin—Pruritus—Gemcitabine—urinary bladder cancer	0.00082	0.00246	CcSEcCtD
Auranofin—Nausea—Thiotepa—urinary bladder cancer	0.000818	0.00246	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—urinary bladder cancer	0.000817	0.00245	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000812	0.00244	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000809	0.00243	CcSEcCtD
Auranofin—Pruritus—Fluorouracil—urinary bladder cancer	0.000806	0.00242	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—urinary bladder cancer	0.000804	0.00241	CcSEcCtD
Auranofin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000793	0.00238	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN1A—urinary bladder cancer	0.000789	0.00185	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000789	0.00237	CcSEcCtD
Auranofin—Urticaria—Etoposide—urinary bladder cancer	0.000786	0.00236	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000784	0.00235	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—urinary bladder cancer	0.000784	0.00235	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000783	0.00184	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—urinary bladder cancer	0.000783	0.00184	CbGpPWpGaD
Auranofin—Abdominal pain—Etoposide—urinary bladder cancer	0.000782	0.00235	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000782	0.00235	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—urinary bladder cancer	0.00078	0.00234	CcSEcCtD
Auranofin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00078	0.00234	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—urinary bladder cancer	0.000777	0.00182	CbGpPWpGaD
Auranofin—Haematuria—Doxorubicin—urinary bladder cancer	0.000767	0.0023	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000767	0.0018	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—IGF1—urinary bladder cancer	0.000765	0.0018	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—IGF1—urinary bladder cancer	0.000765	0.0018	CbGpPWpGaD
Auranofin—Visual impairment—Epirubicin—urinary bladder cancer	0.000752	0.00226	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000751	0.00225	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—EP300—urinary bladder cancer	0.000751	0.00176	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—EP300—urinary bladder cancer	0.000751	0.00176	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—urinary bladder cancer	0.000745	0.00175	CbGpPWpGaD
Auranofin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000739	0.00222	CcSEcCtD
Auranofin—Alopecia—Methotrexate—urinary bladder cancer	0.000737	0.00221	CcSEcCtD
Auranofin—Vomiting—Gemcitabine—urinary bladder cancer	0.000737	0.00221	CcSEcCtD
Auranofin—IKBKB—TCR signaling—PTEN—urinary bladder cancer	0.000734	0.00172	CbGpPWpGaD
Auranofin—Rash—Gemcitabine—urinary bladder cancer	0.000731	0.00219	CcSEcCtD
Auranofin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00073	0.00219	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—urinary bladder cancer	0.00073	0.00219	CcSEcCtD
Auranofin—Vomiting—Fluorouracil—urinary bladder cancer	0.000724	0.00217	CcSEcCtD
Auranofin—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000724	0.0017	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CREBBP—urinary bladder cancer	0.00072	0.00169	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—SRC—urinary bladder cancer	0.00072	0.00169	CbGpPWpGaD
Auranofin—Rash—Fluorouracil—urinary bladder cancer	0.000718	0.00216	CcSEcCtD
Auranofin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000718	0.00215	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—RHOA—urinary bladder cancer	0.000714	0.00168	CbGpPWpGaD
Auranofin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000711	0.00214	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.00071	0.00167	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—RHOA—urinary bladder cancer	0.0007	0.00164	CbGpPWpGaD
Auranofin—Pruritus—Etoposide—urinary bladder cancer	0.0007	0.0021	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000696	0.00209	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—urinary bladder cancer	0.000695	0.00163	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—urinary bladder cancer	0.000693	0.00163	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.00069	0.00162	CbGpPWpGaD
Auranofin—Alopecia—Epirubicin—urinary bladder cancer	0.00069	0.00207	CcSEcCtD
Auranofin—Nausea—Gemcitabine—urinary bladder cancer	0.000688	0.00207	CcSEcCtD
Auranofin—Vomiting—Cisplatin—urinary bladder cancer	0.000687	0.00206	CcSEcCtD
Auranofin—Rash—Cisplatin—urinary bladder cancer	0.000681	0.00204	CcSEcCtD
Auranofin—Dermatitis—Cisplatin—urinary bladder cancer	0.00068	0.00204	CcSEcCtD
Auranofin—IKBKB—Apoptosis—CDKN2A—urinary bladder cancer	0.000678	0.00159	CbGpPWpGaD
Auranofin—Diarrhoea—Etoposide—urinary bladder cancer	0.000677	0.00203	CcSEcCtD
Auranofin—Nausea—Fluorouracil—urinary bladder cancer	0.000677	0.00203	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000675	0.00203	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—MMP9—urinary bladder cancer	0.000675	0.00158	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PRSS3—urinary bladder cancer	0.000674	0.00158	CbGpPWpGaD
Auranofin—Anaemia—Methotrexate—urinary bladder cancer	0.000671	0.00202	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—PTEN—urinary bladder cancer	0.000671	0.00157	CbGpPWpGaD
Auranofin—Flatulence—Epirubicin—urinary bladder cancer	0.00067	0.00201	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000666	0.002	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—PTEN—urinary bladder cancer	0.000663	0.00156	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RBX1—urinary bladder cancer	0.000659	0.00155	CbGpPWpGaD
Auranofin—Leukopenia—Methotrexate—urinary bladder cancer	0.00065	0.00195	CcSEcCtD
Auranofin—Nausea—Cisplatin—urinary bladder cancer	0.000642	0.00193	CcSEcCtD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—EP300—urinary bladder cancer	0.00064	0.0015	CbGpPWpGaD
Auranofin—Alopecia—Doxorubicin—urinary bladder cancer	0.000638	0.00192	CcSEcCtD
Auranofin—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	0.000637	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—urinary bladder cancer	0.000636	0.00149	CbGpPWpGaD
Auranofin—Vomiting—Etoposide—urinary bladder cancer	0.000629	0.00189	CcSEcCtD
Auranofin—Anaemia—Epirubicin—urinary bladder cancer	0.000628	0.00189	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000627	0.00147	CbGpPWpGaD
Auranofin—Rash—Etoposide—urinary bladder cancer	0.000624	0.00187	CcSEcCtD
Auranofin—Dermatitis—Etoposide—urinary bladder cancer	0.000623	0.00187	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—SRC—urinary bladder cancer	0.000622	0.00146	CbGpPWpGaD
Auranofin—Flatulence—Doxorubicin—urinary bladder cancer	0.00062	0.00186	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—VHL—urinary bladder cancer	0.000618	0.00145	CbGpPWpGaD
Auranofin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000616	0.00185	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—SRC—urinary bladder cancer	0.000614	0.00144	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—KRAS—urinary bladder cancer	0.000614	0.00144	CbGpPWpGaD
Auranofin—Leukopenia—Epirubicin—urinary bladder cancer	0.000608	0.00183	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—urinary bladder cancer	0.000605	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—urinary bladder cancer	0.000601	0.00141	CbGpPWpGaD
Auranofin—Nausea—Etoposide—urinary bladder cancer	0.000588	0.00176	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—urinary bladder cancer	0.000581	0.00175	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00058	0.00174	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—FAS—urinary bladder cancer	0.000579	0.00136	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000575	0.00135	CbGpPWpGaD
Auranofin—Anorexia—Methotrexate—urinary bladder cancer	0.000565	0.0017	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000563	0.00169	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—SRC—urinary bladder cancer	0.000561	0.00132	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—urinary bladder cancer	0.000551	0.00129	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000548	0.00129	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—urinary bladder cancer	0.000548	0.00129	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—urinary bladder cancer	0.000545	0.00128	CbGpPWpGaD
Auranofin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000543	0.00163	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—urinary bladder cancer	0.000539	0.00126	CbGpPWpGaD
Auranofin—Anorexia—Epirubicin—urinary bladder cancer	0.000529	0.00159	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—urinary bladder cancer	0.000526	0.00124	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—urinary bladder cancer	0.000525	0.00123	CbGpPWpGaD
Auranofin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000522	0.00157	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—urinary bladder cancer	0.000522	0.00123	CbGpPWpGaD
Auranofin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000515	0.00155	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—KRAS—urinary bladder cancer	0.000515	0.00121	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—KRAS—urinary bladder cancer	0.000515	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—KRAS—urinary bladder cancer	0.000509	0.00119	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000506	0.00119	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNA2—urinary bladder cancer	0.000505	0.00119	CbGpPWpGaD
Auranofin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000503	0.00151	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—urinary bladder cancer	0.000501	0.00118	CbGpPWpGaD
Auranofin—Anorexia—Doxorubicin—urinary bladder cancer	0.000489	0.00147	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000488	0.00147	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000485	0.00146	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000482	0.00145	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL2—urinary bladder cancer	0.000481	0.00113	CbGpPWpGaD
Auranofin—Constipation—Epirubicin—urinary bladder cancer	0.000474	0.00142	CcSEcCtD
Auranofin—Urticaria—Methotrexate—urinary bladder cancer	0.000471	0.00141	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000469	0.00141	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—urinary bladder cancer	0.000466	0.00109	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FGFR3—urinary bladder cancer	0.000464	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—urinary bladder cancer	0.000459	0.00108	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000454	0.00136	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—urinary bladder cancer	0.000452	0.00106	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000452	0.00106	CbGpPWpGaD
Auranofin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000452	0.00136	CcSEcCtD
Auranofin—IKBKB—Innate Immune System—BIRC3—urinary bladder cancer	0.00045	0.00106	CbGpPWpGaD
Auranofin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000446	0.00134	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—urinary bladder cancer	0.000442	0.00104	CbGpPWpGaD
Auranofin—Urticaria—Epirubicin—urinary bladder cancer	0.000441	0.00132	CcSEcCtD
Auranofin—Constipation—Doxorubicin—urinary bladder cancer	0.000439	0.00132	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000438	0.00132	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—urinary bladder cancer	0.000438	0.00103	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—urinary bladder cancer	0.000438	0.00103	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—HRAS—urinary bladder cancer	0.000432	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—urinary bladder cancer	0.000432	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—urinary bladder cancer	0.000428	0.00101	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—urinary bladder cancer	0.000428	0.00101	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.00042	0.000987	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00042	0.00126	CcSEcCtD
Auranofin—Pruritus—Methotrexate—urinary bladder cancer	0.000419	0.00126	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—urinary bladder cancer	0.000411	0.000965	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—urinary bladder cancer	0.00041	0.000962	CbGpPWpGaD
Auranofin—Urticaria—Doxorubicin—urinary bladder cancer	0.000408	0.00122	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000406	0.00122	CcSEcCtD
Auranofin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000406	0.00122	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.0004	0.00094	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—urinary bladder cancer	0.000398	0.000935	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—urinary bladder cancer	0.000395	0.000928	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—KRAS—urinary bladder cancer	0.000395	0.000927	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRSS3—urinary bladder cancer	0.000393	0.000922	CbGpPWpGaD
Auranofin—Pruritus—Epirubicin—urinary bladder cancer	0.000392	0.00118	CcSEcCtD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000391	0.000919	CbGpPWpGaD
Auranofin—Diarrhoea—Epirubicin—urinary bladder cancer	0.00038	0.00114	CcSEcCtD
Auranofin—IKBKB—Apoptosis—TP53—urinary bladder cancer	0.000377	0.000886	CbGpPWpGaD
Auranofin—Vomiting—Methotrexate—urinary bladder cancer	0.000377	0.00113	CcSEcCtD
Auranofin—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000377	0.000885	CbGpPWpGaD
Auranofin—IKBKB—Immune System—VHL—urinary bladder cancer	0.000375	0.00088	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—urinary bladder cancer	0.000374	0.000879	CbGpPWpGaD
Auranofin—Rash—Methotrexate—urinary bladder cancer	0.000374	0.00112	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—urinary bladder cancer	0.000373	0.00112	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—urinary bladder cancer	0.000366	0.000861	CbGpPWpGaD
Auranofin—Pruritus—Doxorubicin—urinary bladder cancer	0.000363	0.00109	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—urinary bladder cancer	0.000357	0.000839	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RBX1—urinary bladder cancer	0.000355	0.000833	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—urinary bladder cancer	0.000354	0.000831	CbGpPWpGaD
Auranofin—Vomiting—Epirubicin—urinary bladder cancer	0.000353	0.00106	CcSEcCtD
Auranofin—IKBKB—Immune System—MT2A—urinary bladder cancer	0.000352	0.000827	CbGpPWpGaD
Auranofin—Nausea—Methotrexate—urinary bladder cancer	0.000352	0.00106	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000351	0.00105	CcSEcCtD
Auranofin—Rash—Epirubicin—urinary bladder cancer	0.00035	0.00105	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—urinary bladder cancer	0.000349	0.00105	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—KRAS—urinary bladder cancer	0.000347	0.000816	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—urinary bladder cancer	0.000342	0.000802	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGFR3—urinary bladder cancer	0.000341	0.000802	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000337	0.000792	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—urinary bladder cancer	0.000336	0.000788	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—SRC—urinary bladder cancer	0.000333	0.000782	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB2—urinary bladder cancer	0.000331	0.000776	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PTEN—urinary bladder cancer	0.00033	0.000776	CbGpPWpGaD
Auranofin—Nausea—Epirubicin—urinary bladder cancer	0.000329	0.000989	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000327	0.000768	CbGpPWpGaD
Auranofin—Vomiting—Doxorubicin—urinary bladder cancer	0.000326	0.00098	CcSEcCtD
Auranofin—Rash—Doxorubicin—urinary bladder cancer	0.000324	0.000972	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000323	0.000971	CcSEcCtD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000323	0.000758	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—urinary bladder cancer	0.000322	0.000755	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—urinary bladder cancer	0.00032	0.000751	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—urinary bladder cancer	0.000319	0.000749	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1A—urinary bladder cancer	0.000305	0.000717	CbGpPWpGaD
Auranofin—Nausea—Doxorubicin—urinary bladder cancer	0.000305	0.000915	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—urinary bladder cancer	0.000305	0.000715	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—urinary bladder cancer	0.000295	0.000693	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—urinary bladder cancer	0.000286	0.000672	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNA2—urinary bladder cancer	0.000283	0.000665	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1A—urinary bladder cancer	0.000283	0.000663	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PTEN—urinary bladder cancer	0.000282	0.000662	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—urinary bladder cancer	0.000274	0.000644	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—S100B—urinary bladder cancer	0.000268	0.000629	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000266	0.000626	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—urinary bladder cancer	0.000264	0.00062	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RHOA—urinary bladder cancer	0.000263	0.000617	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BIRC3—urinary bladder cancer	0.000262	0.000615	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—urinary bladder cancer	0.000259	0.000609	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—urinary bladder cancer	0.000258	0.000606	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—urinary bladder cancer	0.000248	0.000581	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—urinary bladder cancer	0.000246	0.000577	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—urinary bladder cancer	0.000245	0.000575	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—urinary bladder cancer	0.000244	0.000573	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—urinary bladder cancer	0.000243	0.000571	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC4—urinary bladder cancer	0.000242	0.000569	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—urinary bladder cancer	0.000242	0.000568	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000234	0.000551	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—urinary bladder cancer	0.000234	0.000549	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—urinary bladder cancer	0.000229	0.000538	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	0.000224	0.000527	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTZ1—urinary bladder cancer	0.000223	0.000524	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.000218	0.000512	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—urinary bladder cancer	0.000217	0.000509	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—urinary bladder cancer	0.000216	0.000508	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—urinary bladder cancer	0.000216	0.000506	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RBX1—urinary bladder cancer	0.000215	0.000505	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTO2—urinary bladder cancer	0.000212	0.000497	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAT1—urinary bladder cancer	0.000212	0.000497	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—urinary bladder cancer	0.000208	0.000489	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000208	0.000489	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1A—urinary bladder cancer	0.000208	0.000488	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PTEN—urinary bladder cancer	0.000207	0.000487	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLI1—urinary bladder cancer	0.000203	0.000477	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—urinary bladder cancer	0.000199	0.000467	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGFR3—urinary bladder cancer	0.000195	0.000457	CbGpPWpGaD
Auranofin—ALB—Metabolism—UGT2B7—urinary bladder cancer	0.000194	0.000455	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—SRC—urinary bladder cancer	0.000192	0.000452	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGFR3—urinary bladder cancer	0.000187	0.000439	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000186	0.000438	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—urinary bladder cancer	0.000184	0.000432	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00018	0.000423	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP4B1—urinary bladder cancer	0.000174	0.000409	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.000171	0.000401	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—urinary bladder cancer	0.000169	0.000396	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA2—urinary bladder cancer	0.000166	0.00039	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CREBBP—urinary bladder cancer	0.000166	0.000389	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA2—urinary bladder cancer	0.000165	0.000387	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC19A1—urinary bladder cancer	0.000165	0.000387	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	0.000162	0.000381	CbGpPWpGaD
Auranofin—ALB—Metabolism—PRSS3—urinary bladder cancer	0.00016	0.000377	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—urinary bladder cancer	0.000159	0.000374	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—urinary bladder cancer	0.000158	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Immune System—S100B—urinary bladder cancer	0.000156	0.000366	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.000143	0.000336	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RBX1—urinary bladder cancer	0.000139	0.000327	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—urinary bladder cancer	0.000139	0.000326	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	0.000138	0.000323	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—urinary bladder cancer	0.000135	0.000318	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—urinary bladder cancer	0.000133	0.000313	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC1—urinary bladder cancer	0.000131	0.000307	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000129	0.000302	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMP—urinary bladder cancer	0.000128	0.000301	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000125	0.000294	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JAG1—urinary bladder cancer	0.000124	0.000292	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000123	0.000289	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—urinary bladder cancer	0.000119	0.000279	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—urinary bladder cancer	0.000118	0.000278	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAU—urinary bladder cancer	0.000118	0.000277	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAT2—urinary bladder cancer	0.000116	0.000272	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—urinary bladder cancer	0.000114	0.000267	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—urinary bladder cancer	0.000114	0.000267	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR3—urinary bladder cancer	0.000113	0.000266	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—urinary bladder cancer	0.000113	0.000265	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—urinary bladder cancer	0.00011	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—urinary bladder cancer	0.000105	0.000248	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—S100B—urinary bladder cancer	0.000101	0.000237	CbGpPWpGaD
Auranofin—ALB—Metabolism—RRM2—urinary bladder cancer	0.0001	0.000235	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CREBBP—urinary bladder cancer	9.73e-05	0.000228	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREBBP—urinary bladder cancer	9.65e-05	0.000227	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—urinary bladder cancer	9.62e-05	0.000226	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—urinary bladder cancer	9.61e-05	0.000226	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—urinary bladder cancer	9.58e-05	0.000225	CbGpPWpGaD
Auranofin—ALB—Metabolism—HPGDS—urinary bladder cancer	9.27e-05	0.000218	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—urinary bladder cancer	9.27e-05	0.000218	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—urinary bladder cancer	9.24e-05	0.000217	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.22e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—urinary bladder cancer	9.09e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCOR1—urinary bladder cancer	9.06e-05	0.000213	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—urinary bladder cancer	8.99e-05	0.000211	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.86e-05	0.000208	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RHOA—urinary bladder cancer	8.8e-05	0.000207	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—urinary bladder cancer	8.73e-05	0.000205	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.42e-05	0.000198	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—urinary bladder cancer	8.08e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—urinary bladder cancer	7.99e-05	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—urinary bladder cancer	7.72e-05	0.000181	CbGpPWpGaD
Auranofin—ALB—Metabolism—NQO1—urinary bladder cancer	7.47e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—urinary bladder cancer	7.42e-05	0.000174	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—urinary bladder cancer	7.38e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR3—urinary bladder cancer	7.33e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—urinary bladder cancer	7.33e-05	0.000172	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.25e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—urinary bladder cancer	7.12e-05	0.000167	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—urinary bladder cancer	6.91e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—urinary bladder cancer	6.89e-05	0.000162	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—urinary bladder cancer	6.63e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—urinary bladder cancer	6.57e-05	0.000154	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—urinary bladder cancer	6.44e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—urinary bladder cancer	6.39e-05	0.00015	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.32e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREBBP—urinary bladder cancer	6.24e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—urinary bladder cancer	6.23e-05	0.000146	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—urinary bladder cancer	6.16e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.03e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMS—urinary bladder cancer	5.8e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOR1—urinary bladder cancer	5.73e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—urinary bladder cancer	5.73e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RHOA—urinary bladder cancer	5.65e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—urinary bladder cancer	5.6e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—urinary bladder cancer	5.49e-05	0.000129	CbGpPWpGaD
Auranofin—ALB—Metabolism—ERCC2—urinary bladder cancer	5.39e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—urinary bladder cancer	5.33e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—urinary bladder cancer	5.29e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—urinary bladder cancer	5.23e-05	0.000123	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—urinary bladder cancer	5.06e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—urinary bladder cancer	4.96e-05	0.000116	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—urinary bladder cancer	4.74e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—urinary bladder cancer	4.74e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—urinary bladder cancer	4.62e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—urinary bladder cancer	4.53e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—urinary bladder cancer	4.5e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—urinary bladder cancer	4.48e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—urinary bladder cancer	4.47e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—urinary bladder cancer	4.46e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—urinary bladder cancer	4.25e-05	9.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—urinary bladder cancer	4.13e-05	9.71e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—urinary bladder cancer	4.11e-05	9.64e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CREBBP—urinary bladder cancer	3.94e-05	9.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—urinary bladder cancer	3.7e-05	8.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—urinary bladder cancer	3.62e-05	8.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—urinary bladder cancer	3.42e-05	8.04e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—urinary bladder cancer	3.23e-05	7.59e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—urinary bladder cancer	3.04e-05	7.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—urinary bladder cancer	2.91e-05	6.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—urinary bladder cancer	2.82e-05	6.62e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—urinary bladder cancer	2.69e-05	6.31e-05	CbGpPWpGaD
